The Radiologists’ Role in Diagnosing Lung Toxicity from Anti-Cancer Drugs (2024)

Create Account

Availability

On-Demand

Expires on Sep 11, 2025

Cost

$0.00

Credit Offered

No Credit Offered

Sponsored by:

Enhance your understanding of interstitial lung disease (ILD)/pneumonitis related to anti-cancer drugs during this free, one-hour webinar sponsored by AstraZeneca and Daiichi Sankyo and for HCPs only. Leading experts will share best practices and valuable insight related to ILD/pneumonitis risk factors, early diagnosis, the radiologist’s role within multi-disciplinary teams, and the monitoring and management of potential toxicity.

Content Areas (Codes):
The following Content Areas will be printed on the certificate for this course:

Chest Radiology
Computed Tomography
Oncologic Imaging

This Other activity (blended live and enduring material) is estimated to take 1 hour to complete.

Start Date: 9/12/2024
Online Expiration Date: 9/11/2025

This educational activity was originally presented on 9/12/2024 as an interactive online webinar.

Faculty:

Julien Dinkel, MD
Nikolaus Kneidinger, MD

Price:
Non-Member/Basic Member Rate: $0.00
Standard Member/Full Access Member Rate: $0.00

Refund / Exchange Policy:
RSNA will not issue any refunds or exchanges for online only versions of educational products or activities purchased online. Please review the entire product or activity description prior to purchase.

RSNA Disclaimer:
The opinions or views expressed in this activity are those of the presenters and do not necessarily reflect the opinions, recommendations or endorsement of the RSNA. Participants should critically appraise the information presented and are encouraged to consult appropriate resources for information surrounding any product or device mentioned. Information presented, as well as publications, technologies, products and/or services discussed, are intended to inform the learner about the knowledge, techniques, and experiences of RSNA faculty who are willing to share such information with colleagues. The RSNA disclaims any and all liability for damages to any individual user for all claims which may result from the use of said information, publications, technologies, products and/or services, and events.